MARKET WIRE NEWS

Iterum Therapeutics plc (ITRM) Q4 2024 Earnings Call Transcript

Source: SeekingAlpha

2025-02-07 10:20:15 ET

Iterum Therapeutics plc (ITRM)

Q4 2024 Earnings Conference Call

February 07, 2025 08:30 AM ET

Company Participants

Louise Barrett - SVP, Legal Affairs

Corey Fishman - CEO

Judy Matthews - CFO

Conference Call Participants

Thomas Yip - H.C. Wainwright

Presentation

Operator

Hello, everyone. And welcome to the Iterum Therapeutics plc Fourth Quarter and Full Year 2024 financial results. My name is Ezra, and I will be your coordinator today [Operator Instructions]. I will now hand you over to Louise Barrett, Senior Vice President, Legal Affairs, to begin. Louise, please go ahead....

Read the full article on Seeking Alpha

For further details see:

Iterum Therapeutics plc (ITRM) Q4 2024 Earnings Call Transcript
Iterum Therapeutics plc

NASDAQ: ITRM

ITRM Trading

1.0% G/L:

$0.1719 Last:

229,900 Volume:

$0.177 Open:

mwn-app Ad 300

ITRM Latest News

February 13, 2026 08:00:00 am
Iterum Therapeutics Provides Business Update

ITRM Stock Data

$15,988,461
51,778,499
0.46%
14
N/A
Biotechnology & Life Sciences
Healthcare
IE
Dublin 1

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App